// App-Quantinova.ai

PD5-08 : Expression of LAG-3 in breast cancer, and its association with subtype and outcome

Researchers

Presenter

  • S Burugu

Principal Investigators

  • D Gao

  • TO Nielsen

Medical Centers

  • Genetic Pathology Evaluation Centre, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Progesterone receptor

  • Proliferation marker protein Ki-67

  • erb-b2 receptor tyrosine kinase 2

  • Stromal tumor infiltrating lymphocytes

  • tumor-infiltrating lymphocytes

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved